Global Micro Positron Emission Tomography Pet Systems Market
Tamanho do mercado em biliões de dólares
CAGR :
% 
USD
975.00 Million
USD
1,440.52 Million
2021
2029
 Período de previsão |
2022 –2029 |
 Tamanho do mercado (ano base ) | USD 975.00 Million |
 Tamanho do mercado ( Ano de previsão) | USD 1,440.52 Million |
 CAGR |
% |
| Principais participantes do mercado |
|
Global Micro-Positron Emission Tomography (PET) Systems Market, By Applications (Cardiology, Neurology, Oncology, Orthopedics, Urology, Gastroenterology, Others), End User (Hospitals, Clinics, Diagnostic Centers, Others) – Industry Trends and Forecast to 2029.
Market Analysis and Size
In recent years, micro- positron emission tomography (PET) systems have been highly utilized in both the medical and research fields. These systems are used along with magnetic resonance imaging (MRI) scans and computed tomography (CT) for diagnosing epilepsy, coronary artery disease, lung cancer and Alzheimer's disease, among others.
Global Micro- Positron Emission Tomography (PET) Systems Market was valued at USD 975 million in 2021 and is expected to reach USD 1440.52 million by 2029, registering a CAGR of 5.00% during the forecast period of 2022-2029. “Hospitals” accounts for the most prominent end user segment in the respective market owing to the rise in the number of cancer cases. The market report curated by DBMR research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Micro-positron emission tomography (PET) refers to a combination of nuclear medicine and biochemical analysis is utilized for measuring the metabolic activity of cells. This combination is administered a small amount of radioactive glucose (sugar) into the patient’s vein through an intravenous (IV) line. Detailed pictures of areas containing the glucose is generated with the assistance of a scanner and computer. PET is used for early detection of heart diseases, brain disorders and cancer.
Report Scope and Market Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2019 - 2014) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Applications (Cardiology, Neurology, Oncology, Orthopedics, Urology, Gastroenterology, Others), End User (Hospitals, Clinics, Diagnostic Centers, Others) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
|
Market Players Covered |
Positron Corporation (US), CellSight Technologies. (US), RefleXion. (Canada), Clarity Pharmaceuticals (Australia), PETsys Electronics SA (Portugal), Blue Earth Diagnostics Limited. (UK), Qubiotech Health Intelligence S.L. (Spain), Advanced Accelerator Applications (France), Lily. (US), Agfa-Gevaert Group. (Belgium), CMR Naviscan. (US), Neusoft Corporation (China), Siemens (Germany), Segamicorp (US), ONCOVISION. (Spain), MedX Holdings, Inc (US), Modus Medical Devices Inc. (Canada), Radiology Oncology Systems (US), TOSHIBA CORPORATION (Japan), and General Electric Company (US), among others |
|
Market Opportunities |
|
Micro-Positron Emission Tomography (PET) Systems Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
- Prevalence of Cancer
The increase in the prevalence of cancer acts as one of the major factors driving the growth micro- positron emission tomography (PET) systems market. With the increase in the cases of cancer, the demand for enhanced diagnostics and treatment is rising.
- Continuous Support for Cancer Research
The continuous support for cancer research from the public and private sectors in the form of funds and investments accelerate the market growth.
- Research and Development
The surge in the number of research and development activities to enhance the treatment options available further influence the market. The advancement in the technology declines the acquisition time and offers high sensitivity and specifity.
Opportunities
Furthermore, popularity of the hybrid imaging systems extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, technological development will further expand the market.
Restraints/Challenges
On the other hand, stringent regulatory rules are expected to obstruct market growth. Also, high cost associated with the scanners is projected to challenge the micro-positron emission tomography (PET) systems market in the forecast period of 2022-2029.
This micro-positron emission tomography (PET) systems market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on micro-positron emission tomography (PET) systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 Impact on Micro-Positron Emission Tomography (PET) Systems Market
COVID-19 had both positive and negative impact on the micro- positron emission tomography (PET) systems market. The decline in the productivity in life science organizations during the pandemic impacted the market. However, PET emerged as a great potential in the improvement and management of COVID-19 that accelerated the demand for micro- positron emission tomography (PET) systems. The market is expected to witness health growth post-pandemic as well owing to its application in combating various other epidemics in the future.
Recent Development
- Siemens Healthineers announced the news of FDA clearance for Biograph Vision Quadra PET/CT Scanner in March’2021. The product is specifically for clinical use and translational research-or the application of scientific research for creating procedures and therapies that enhance health outcomes.
Global Micro-Positron Emission Tomography (PET) Systems Market Scope and Market Size
The micro-positron emission tomography (PET) systems market is segmented on the basis of applications and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Applications
- Cardiology
- Neurology
- Oncology
- Orthopedics
- Urology
- Gastroenterology
- Others
On the basis of applications, the micro-positron emission tomography (PET) systems market is segmented into cardiology, neurology, oncology, orthopedics, urology, gastroenterology and others.
End User
- Hospitals
- Clinics
- Diagnostic Centers
- Others
On the basis of end user, the micro-positron emission tomography (PET) systems market is segmented into hospitals, clinics, diagnostic centers and others.
Micro-Positron Emission Tomography (PET) Systems Market Regional Analysis/Insights
The micro-positron emission tomography (PET) systems market is analysed and market size insights and trends are provided by country, applications and end user as referenced above.
The countries covered in the micro-positron emission tomography (PET) systems market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the micro-positron emission tomography (PET) systems market because of the increased risks in patients with cardiovascular disease and cancer within the region.
Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the large patient population in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The micro-positron emission tomography (PET) systems market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for micro-positron emission tomography (PET) systems market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the micro-positron emission tomography (PET) systems market. The data is available for historic period 2010-2020.
Competitive Landscape and Micro-Positron Emission Tomography (PET) Systems Market Share Analysis
The micro-positron emission tomography (PET) systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to micro-positron emission tomography (PET) systems market.
Some of the major players operating in the micro-positron emission tomography (PET) systems market are
- Positron Corporation (US)
- CellSight Technologies. (US)
- RefleXion. (Canada)
- Clarity Pharmaceuticals (Australia)
- PETsys Electronics SA (Portugal)
- Blue Earth Diagnostics Limited. (UK)
- Qubiotech Health Intelligence S.L. (Spain)
- Advanced Accelerator Applications (France)
- Lily. (US)
- Agfa-Gevaert Group. (Belgium)
- CMR Naviscan. (US)
- Neusoft Corporation (China)
- Siemens (Germany)
- Segamicorp (US)
- ONCOVISION. (Spain)
- MedX Holdings, Inc (US)
- Modus Medical Devices Inc. (Canada)
- Radiology Oncology Systems (US)
- TOSHIBA CORPORATION (Japan)
- General Electric Company (US)
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
